Publications by authors named "Li-Xiang Fu"

Claim this Profile
T
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Huan Zhou, Li-Xiang Fu, Li Li, Yan-Yan Chen, Hong-Qing Zhu

J Ethnopharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epigallocatechin gallate derivative Y inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways.
Zhi-Hong Liao, Hong-Qing Zhu, Yan-Yan Chen, Run-Li Chen, Li-Xiang Fu

J Ethnopharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.
Yan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, Pranav Gupta, Li-Xiang Fu

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis